2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Metabolic

32.36 - Pre-Transplant Hyponatremia Could Be Associated With A Poor Prognosis After Liver Transplantation

Presenter: Ilka, Boin, Campinas, Brazil
Authors: Boin I., Capel C., Ataide E., Cardoso A., Caruy C., Stucchi R.

PRE-TRANSPLANT HYPONATREMIA COULD BE ASSOCIATED WITH A POOR PROGNOSIS AFTER LIVER TRANSPLANTATION

COMPLICATIONS - METABOLIC

I.F.S.F. Boin1, C. Capel2, E.C. Ataide1, A.R. Cardoso1, C.A. Caruy1, R.S.B. Stucchi1
1Unit Of Liver Transplantation, State University of Campinas, Campinas/BRAZIL, 2Surgery, Faculty of Medical Science, Campinas/BRAZIL

Body: Introduction: Predicting prognosis at the most accurate way in hepatic cirrhosis is essential to do a fairness allocation in liver transplantation waiting list and reduce mortality. Several researchers presently are comparing MELD to MELD Na with results pointing to the second parameter as a better instrument to evaluate the prognosis in liver cirrhosis.
Aim: To study the survival rate of the recipient liver transplantation in association with hyponatremia.
Method: This is an analytic and retrospective study. The characteristics from liver donor and recipient were: age (years). MELD UNOS score (total bilirubin. creatinine and IRN). MELD Na score (total bilirubin. creatinine. IRN. natremia). pre-transplant (p-t) BMI (body mass index). warm ischemia time (minutes). cold ischemia time (minutes). ICU time (days). hemocomponents use [cell saver (ml). FFP-frozen fresh plasma (ml). erythrocytes (ml)]. p-t glycemia (mg/dL). p-t serum sodium (mEq/L) and Child-Pugh classification. From February 99 to May all consecutive OLT (piggyback technique) were analyzed. split in two groups for comparison (A – [Na]> mEq/L and B – [Na]<mEq/L). survival (months). The Kaplan-Meier method was used to analyze survival rate and Cox regression test to identify predictive factors.
Results: There was statistical difference in the cumulative proportion surviving between the groups (P=.) by Cox-Mantel test. Cox regression test for survival time showed that patients with higher risk of death in recipients with low values of pre-transplant serum sodium (group B) were: Child-Pugh score with .% plus risk to death for each point. cold ischemia time with .% plus risk to death for each minute. glycemia with .9% plus risk to death for each mg. cell-saver with .66% plus risk to death for each ml. donor [Na] with .% plus risk to death for each mEq and donor age with .% plus risk to death for each year. Kolmogorov-Sminorv test showed that Hyponatremia group (B) had significant difference (black numbers)

p-level Mean A Mean B SD (A) SD (B) Valid N Valid N
Survival time p <.05 51.21 37.16 54.13 51.17 269 49
Age p >.10 46.63 45.44 11.45 12.11 263 47
Child p <.025 9.57 11.02 2.04 2.12 248 43
BMI p <.05 26.15 24.40 4.54 4.24 261 46
Warm ischemia p >.10 64.34 62.37 30.55 23.34 268 48
Cold ischemia p <.05 687.58 630.30 186.72 190.95 269 49
ICU time p >.10 11.04 19.70 15.28 44.73 223 41
MELD UNOS p >.10 18.26 20.47 4.75 5.760 220 40
MELD_NA p <.001 19.03 33.54 5.22 10.55 207 37
Glycemia p <.025 103.78 116.23 43.73 42.26 266 47
Sodium p <.001 136.64 126.57 3.70 4.87 269 49
Hemacea p <.025 6.575 7.625 7.47 5.59 268 48

Conclusion: High Child-Pugh score values. cold ischemia time. glycose levels. use of cell-saver. serum sodium level of donor and donor age are variables that are found associated with the highest number of deaths and shorter survival.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada